Merck Provides Update on Phase 3 Trials KEYNOTE-641 and KEYNOTE-789
Go back to Merck Provides Update on Phase 3 Trials KEYNOTE-641 and KEYNOTE-789| Merck & Co. (NYSE: MRK) | Delayed: 128.37 +0.04 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $128.33 | 52 Week High | $65.46 | |||
| Open | $130.96 | 52 Week Low | $47.97 | |||
| Day High | $131.08 | P/E | 87.33 | |||
| Day Low | $127.80 | EPS | $1.47 | |||
| Volume | 7,052,011 | |||||
